In a talk titled "The Promise and Peril of CRISPR," Dr. Neal Baer discussed the ethical implications of gene editing technology. Co-sponsored by Harvard's Division of Science and Library, the event featured discussions on the benefits of CRISPR in treating diseases like sickle cell anemia while addressing the moral responsibilities that come with such capabilities. Baer's experiences treating sick children highlighted the technology's potential to transform healthcare. Yet, he emphasized that with this power comes a need for careful consideration about the long-term implications of editing not just somatic but also germline genes.
The question of whether we should change our innate differences raises ethical dilemmas, even as CRISPR offers the potential to cure severe diseases like sickle cell anemia.
Neal Baer emphasizes that while CRISPR technology has advanced to allow genetic editing, it also necessitates discussions on ethical responsibilities related to such interventions.
Collection
[
|
...
]